Offices:
Helsinki
Investors:
we tracked 2 investors
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Total investments received (USD) - we tracked 1 transaction
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
TILT Biotherapeutics Ltd is a preclinical stage company working in the field of cancer immunotherapy. TILT aims to translate its unique approach into clinical trials.
The company’s patented technology involves utilization of oncolytic viruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR) and checkpoint inhibiting antibody therapy.
The TILT approach has the potential to achieve similar results in CAR therapy of solid tumors as currently achieved for CD19+ hematological tumors.
Companies with similar profile to TILT Biotherapeutics:
| Company | Criteria |
|---|
 Synoste Oy55% | - Similar verticals: Health services
- Similar business models: B2B
- At least one vc investor: Lifeline Ventures
- At least one other investor: Business Finland
- Total raised in a similar range: 10M+ USD
|
| Oura Health 55% | - Similar verticals: Health services
- Similar business models: B2B
- At least one vc investor: Lifeline Ventures
- At least one other investor: Business Finland
- Total raised in a similar range: 10M+ USD
|
| Valkee 45% | - Similar verticals: Health services
- Similar business models: B2B
- At least one vc investor: Lifeline Ventures
- Total raised in a similar range: 10M+ USD
|
 Galecto Biotech44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| TrademarkNow 44% | - Similar business models: B2B
- At least one vc investor: Lifeline Ventures
- At least one other investor: Business Finland
- Total raised in a similar range: 5M - 10M USD
|
| Iceye 44% | - Similar business models: B2B
- At least one vc investor: Lifeline Ventures
- At least one other investor: Business Finland
- Total raised in a similar range: 10M+ USD
|
 Alvotech44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| Varjo 44% | - Similar business models: B2B
- At least one vc investor: Lifeline Ventures
- At least one other investor: Business Finland
- Total raised in a similar range: 10M+ USD
|
 Monocl44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
|
| Norsepower 44% | - Similar business models: B2B
- At least one vc investor: Lifeline Ventures
- At least one other investor: Business Finland
- Total raised in a similar range: 5M - 10M USD
|
| Gradientech 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 5M - 10M USD
|
| Nanoform Finland 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| BoneSupport 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| MinervaX 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| AFYX Therapeutics 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| Cavidi 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| Mobidiag 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| Aprea Therapeutics 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| ITBMed 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| NMD Pharma 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
